Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Display Settings
النتائج لكل صفحة: 10
Sort By: Relevance
Filter
  • 1-10 ل  253 نتائج ل ""Hypolipidemic Agents""

فلترة النتائج

Publisher : biomed central
إعادة تعيين خيارات الفبترة
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

The importance of paying attention to the role of lipid-lowering drugs in controlling dengue virus infection.

Subjects: Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/pharmacology ; Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/therapeutic use ; Dengue*/Dengue*/Dengue*/drug therapy

  • Source: Virology journal [Virol J] 2024 Dec 19; Vol. 21 (1), pp. 324. Date of Electronic Publication: 2024 Dec 19.Publisher: BioMed Central Country of Publication: England NLM ID: 101231645 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Lipid-lowering drugs and risk of rapid renal function decline: a mendelian randomization study.

  • Authors : Zhao Z; Graduate school of Tianjin Medical University, Tianjin, 300070, China.; Department of Cardiology, Tianjin Chest Hospital, Tianjin University, Tianjin, 300222, China.

Subjects: Mendelian Randomization Analysis* ; Hypolipidemic Agents*/Hypolipidemic Agents*/Hypolipidemic Agents*/therapeutic use ; Hypolipidemic Agents*/Hypolipidemic Agents*/Hypolipidemic Agents*/adverse effects

  • Source: BMC medical genomics [BMC Med Genomics] 2024 Oct 08; Vol. 17 (1), pp. 248. Date of Electronic Publication: 2024 Oct 08.Publisher: BioMed Central Country of Publication: England NLM ID: 101319628 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Fenofibrate to prevent amputation and reduce vascular complications in patients with diabetes: FENO-PREVENT.

  • Authors : Ku EJ; Department of Internal Medicine, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, South Korea.; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea.

Subjects: Fenofibrate*/Fenofibrate*/Fenofibrate*/therapeutic use ; Fenofibrate*/Fenofibrate*/Fenofibrate*/adverse effects ; Amputation, Surgical*/Amputation, Surgical*/Amputation, Surgical*/adverse effects

  • Source: Cardiovascular diabetology [Cardiovasc Diabetol] 2024 Sep 03; Vol. 23 (1), pp. 329. Date of Electronic Publication: 2024 Sep 03.Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Cardiometabolic benefits of fenofibrate in heart failure related to obesity and diabetes.

  • Authors : Park J; Department of Biomedical Science and Engineering, Gwangju Institute of Science and Technology, Gwangju, Korea.; Song H

Subjects: Fenofibrate*/Fenofibrate*/Fenofibrate*/therapeutic use ; Fenofibrate*/Fenofibrate*/Fenofibrate*/pharmacology ; Obesity*/Obesity*/Obesity*/drug therapy

  • Source: Cardiovascular diabetology [Cardiovasc Diabetol] 2024 Sep 16; Vol. 23 (1), pp. 343. Date of Electronic Publication: 2024 Sep 16.Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Repurposing lipid-lowering drugs on asthma and lung function: evidence from a genetic association analysis.

  • Authors : Zhang Y; Department of Pediatrics, Xiangya Hospital, Central South University, Hunan, 410008, China.; Jiang Z

Subjects: Asthma*/Asthma*/Asthma*/genetics ; Asthma*/Asthma*/Asthma*/drug therapy ; Hypolipidemic Agents*/Hypolipidemic Agents*/Hypolipidemic Agents*/therapeutic use

  • Source: Journal of translational medicine [J Transl Med] 2024 Jul 03; Vol. 22 (1), pp. 615. Date of Electronic Publication: 2024 Jul 03.Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Identification of lipid-modifying drug targets for autoimmune diseases: insights from drug target mendelian randomization.

  • Authors : Hu X; Department of Health Promotion and Behavioral Sciences, School of Public Health, Anhui Medical University, 81 Meishan Road, Hefei, Anhui, 230032, China.; Institute of Kidney Disease, Inflammation & Immunity Mediated Diseases, The Second Hospital of Anhui Medical University, Hefei, China.

Subjects: Mendelian Randomization Analysis* ; Autoimmune Diseases*/Autoimmune Diseases*/Autoimmune Diseases*/genetics ; Autoimmune Diseases*/Autoimmune Diseases*/Autoimmune Diseases*/drug therapy

  • Source: Lipids in health and disease [Lipids Health Dis] 2024 Jun 22; Vol. 23 (1), pp. 193. Date of Electronic Publication: 2024 Jun 22.Publisher: BioMed Central Country of Publication: England NLM ID: 101147696 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Triglyceride-lowering therapies in hypertriglyceridemia-associated acute pancreatitis in China: a multicentre prospective cohort study.

Subjects: Hypertriglyceridemia*/Hypertriglyceridemia*/Hypertriglyceridemia*/drug therapy ; Hypertriglyceridemia*/Hypertriglyceridemia*/Hypertriglyceridemia*/complications ; Triglycerides*/Triglycerides*/Triglycerides*/blood

  • Source: BMC medicine [BMC Med] 2024 Nov 15; Vol. 22 (1), pp. 535. Date of Electronic Publication: 2024 Nov 15.Publisher: BioMed Central Country of Publication: England NLM ID: 101190723 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Association between lipid-lowering agents with intervertebral disc degeneration, sciatica and low back pain: a drug-targeted mendelian randomized study and cross-sectional observation.

  • Authors : Liu C; School of Basic Medicine, Hebei University of Chinese Medicine, Shijiazhuang, Hebei, China.; Chu X

Subjects: Intervertebral Disc Degeneration*/Intervertebral Disc Degeneration*/Intervertebral Disc Degeneration*/genetics ; Intervertebral Disc Degeneration*/Intervertebral Disc Degeneration*/Intervertebral Disc Degeneration*/drug therapy ; Sciatica*/Sciatica*/Sciatica*/drug therapy

  • Source: Lipids in health and disease [Lipids Health Dis] 2024 Oct 02; Vol. 23 (1), pp. 327. Date of Electronic Publication: 2024 Oct 02.Publisher: BioMed Central Country of Publication: England NLM ID: 101147696 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Role of the screening with coronary computed tomography angiography on lipid management and risk factors control in an asymptomatic Chinese population: a community-based, parallel-group, open-label, randomized clinical trial (RESPECT2).

  • Authors : Guo X; Department of Radiology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.; Li J

Subjects: Coronary Artery Disease*/Coronary Artery Disease*/Coronary Artery Disease*/diagnostic imaging ; Coronary Artery Disease*/Coronary Artery Disease*/Coronary Artery Disease*/prevention & control ; Computed Tomography Angiography*

  • Source: Trials [Trials] 2024 Sep 30; Vol. 25 (1), pp. 635. Date of Electronic Publication: 2024 Sep 30.Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Exploring the causal effect between lipid-modifying drugs and idiopathic pulmonary fibrosis: a drug-target Mendelian randomization study.

  • Authors : Cai G; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.; Liu J

Subjects: Mendelian Randomization Analysis* ; Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/genetics ; Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/drug therapy

  • Source: Lipids in health and disease [Lipids Health Dis] 2024 Aug 01; Vol. 23 (1), pp. 237. Date of Electronic Publication: 2024 Aug 01.Publisher: BioMed Central Country of Publication: England NLM ID: 101147696 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
  • 1-10 ل  253 نتائج ل ""Hypolipidemic Agents""